Annual report pursuant to Section 13 and 15(d)

Note 11 - Segment Information (Tables)

v3.10.0.1
Note 11 - Segment Information (Tables)
12 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Year Ended June 30,
 
   
201
8
   
201
7
   
201
6
 
Net sales:
                       
Biotechnology
  $
421,536
    $
364,504
    $
317,340
 
Protein Platforms
   
111,885
     
91,464
     
77,324
 
Diagnostics
   
110,108
     
107,139
     
104,484
 
Intersegment
   
(536
)
   
(104
)
   
(125
)
Consolidated net sales
  $
642,993
    $
563,003
    $
499,023
 
                         
Operating Income:
                       
Biotechnology
  $
199,100
    $
175,163
    $
168,613
 
Protein Platforms
   
17,996
     
9,648
     
3,592
 
Diagnostics
   
28,280
     
28,575
     
30,412
 
Segment operating income
   
245,376
     
213,386
     
202,617
 
Costs recognized upon sale of acquired inventory
   
(2,455
)
   
(3,037
)
   
(5,431
)
Amortization of intangibles
   
(46,983
)
   
(44,393
)
   
(29,395
)
Acquisition related expenses
   
(24,429
)
   
(25,789
)
   
(2,761
)
Restructuring costs
   
(376
)
   
-
     
-
 
Stock-based compensation
   
(28,240
)
   
(14,631
)
   
(9,430
)
Corporate general, selling and administrative expenses
   
(6,715
)
   
(4,952
)
   
(5,007
)
Consolidated operating income
  $
136,178
    $
120,584
    $
150,593
 
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
   
Year Ended June 30,
 
   
2018
   
2017
   
2016
 
Net sales:
                       
United States
  $
346,293
    $
313,195
    $
275,859
 
EMEA, excluding U.K.
   
148,599
     
125,126
     
103,060
 
U.K.
   
33,704
     
28,401
     
28,307
 
APAC, excluding Greater China
   
48,392
     
41,463
     
38,137
 
Greater China
   
47,950
     
39,078
     
36,199
 
Rest of world
   
18,055
     
15,740
     
17,461
 
Total external sales
  $
642,993
    $
563,003
    $
499,023
 
                         
Long-lived assets:
                       
United States and Canada
  $
129,360
    $
119,859
    $
116,830
 
Europe
   
14,597
     
14,100
     
14,423
 
China
   
1,391
     
1,165
     
1,109
 
Total long-lived assets
  $
145,348
    $
135,124
    $
132,362
 
     
Year ended
June 30,
 
Long-lived assets:    
2018
     
2017
 
United States and Canada   $
129,360
    $
119,859
 
Europe    
14,597
     
14,100
 
China    
1,391
     
1,165
 
Total long-lived assets   $
145,348
    $
135,124
 
Intangible assets:                
United States and Canada   $
417,430
    $
424,579
 
Europe    
21,386
     
18,710
 
China    
7,516
     
8,753
 
Total intangible assets   $
446,332
    $
452,042